These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20024071)

  • 1. Rapid identification of orexin receptor binding ligands using cell-based screening accelerated with magnetic beads.
    Qi X; Astle J; Kodadek T
    Mol Biosyst; 2010 Jan; 6(1):102-7. PubMed ID: 20024071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and binding kinetic studies make a distinction between OX1 and OX2 orexin receptor antagonists.
    Faedo S; Perdonà E; Antolini M; di Fabio R; Merlo Pich E; Corsi M
    Eur J Pharmacol; 2012 Oct; 692(1-3):1-9. PubMed ID: 22796453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist ligand discrimination by the two orexin receptors depends on the expression system.
    Putula J; Turunen PM; Jäntti MH; Ekholm ME; Kukkonen JP
    Neurosci Lett; 2011 Apr; 494(1):57-60. PubMed ID: 21362456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function.
    Ellis J; Pediani JD; Canals M; Milasta S; Milligan G
    J Biol Chem; 2006 Dec; 281(50):38812-24. PubMed ID: 17015451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists.
    Tran DT; Bonaventure P; Hack M; Mirzadegan T; Dvorak C; Letavic M; Carruthers N; Lovenberg T; Sutton SW
    Eur J Pharmacol; 2011 Sep; 667(1-3):120-8. PubMed ID: 21679703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist.
    Winrow CJ; Gotter AL; Cox CD; Doran SM; Tannenbaum PL; Breslin MJ; Garson SL; Fox SV; Harrell CM; Stevens J; Reiss DR; Cui D; Coleman PJ; Renger JJ
    J Neurogenet; 2011 Mar; 25(1-2):52-61. PubMed ID: 21473737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.
    Malherbe P; Borroni E; Gobbi L; Knust H; Nettekoven M; Pinard E; Roche O; Rogers-Evans M; Wettstein JG; Moreau JL
    Br J Pharmacol; 2009 Apr; 156(8):1326-41. PubMed ID: 19751316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualizing differences in ligand-induced beta-arrestin-GFP interactions and trafficking between three recently characterized G protein-coupled receptors.
    Evans NA; Groarke DA; Warrack J; Greenwood CJ; Dodgson K; Milligan G; Wilson S
    J Neurochem; 2001 Apr; 77(2):476-85. PubMed ID: 11299310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of dual orexin receptor antagonists (DORAs) for the treatment of insomnia.
    Coleman PJ; Cox CD; Roecker AJ
    Curr Top Med Chem; 2011; 11(6):696-725. PubMed ID: 21261591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Receptors for oreksins: structure, localisation and activation mechanisms].
    Abramova TV; Perekrest SV; Shainidze KZ; Novikova NS; Korneva EA
    Ross Fiziol Zh Im I M Sechenova; 2011 Sep; 97(9):995-1007. PubMed ID: 22165210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomedical application of orexin/hypocretin receptor ligands in neuroscience.
    Boss C; Brisbare-Roch C; Jenck F
    J Med Chem; 2009 Feb; 52(4):891-903. PubMed ID: 19199652
    [No Abstract]   [Full Text] [Related]  

  • 12. Arachidonic acid release mediated by OX1 orexin receptors.
    Turunen PM; Ekholm ME; Somerharju P; Kukkonen JP
    Br J Pharmacol; 2010 Jan; 159(1):212-21. PubMed ID: 20002100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists.
    Jiang R; Song X; Bali P; Smith A; Bayona CR; Lin L; Cameron MD; McDonald PH; Kenny PJ; Kamenecka TM
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3890-4. PubMed ID: 22617492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia.
    Cox CD; Breslin MJ; Whitman DB; Schreier JD; McGaughey GB; Bogusky MJ; Roecker AJ; Mercer SP; Bednar RA; Lemaire W; Bruno JG; Reiss DR; Harrell CM; Murphy KL; Garson SL; Doran SM; Prueksaritanont T; Anderson WB; Tang C; Roller S; Cabalu TD; Cui D; Hartman GD; Young SD; Koblan KS; Winrow CJ; Renger JJ; Coleman PJ
    J Med Chem; 2010 Jul; 53(14):5320-32. PubMed ID: 20565075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexin receptor antagonists: a new concept in CNS disorders?
    Gatfield J; Brisbare-Roch C; Jenck F; Boss C
    ChemMedChem; 2010 Aug; 5(8):1197-214. PubMed ID: 20544785
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovery of a functional immunoreceptor tyrosine-based switch motif in a 7-transmembrane-spanning receptor: role in the orexin receptor OX1R-driven apoptosis.
    El Firar A; Voisin T; Rouyer-Fessard C; Ostuni MA; Couvineau A; Laburthe M
    FASEB J; 2009 Dec; 23(12):4069-80. PubMed ID: 19661287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor binding.
    Cox CD; McGaughey GB; Bogusky MJ; Whitman DB; Ball RG; Winrow CJ; Renger JJ; Coleman PJ
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2997-3001. PubMed ID: 19406641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
    Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
    Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
    Hoyer D; Bartfai T
    Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of orexin-A binding to phospholipase C inhibitors, neuropeptide Y, and secretin.
    Kane JK; Tanaka H; Parker SL; Yanagisawa M; Li MD
    Biochem Biophys Res Commun; 2000 Jun; 272(3):959-65. PubMed ID: 10860858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.